Sport Physiology

Current Issue

By Issue

By Author

By Subject

Author Index

Keyword Index

About Journal

Aims and Scope

Editorial Board

Article Processing Charges (APC)

Indexing and Abstracting

Related Links

FAQ

Reviewers

Terms and conditions for manuscript submission

Submission Instruction

Forms

Peer Review Process

Effects of 8 Weeks Aerobic Exercise Training on Plasma Levels of Pentraxin3 and C-Reactive Protein in Diabetic and Non-Diabetic Coronary Artery Disease Patients after Revascularization Interventions

Document Type : Research Paper

Authors

1 PhD Student of Sport Physiology, Mohaghegh Ardebili University

2 Professor of Sport Physiology, Mohaghegh Ardebili University

3 Assistant Professor of Interventional Electrophysiology, Shahid Beheshti Hospital, Kashan University of Medical Sciences

4 Student Research Committee, Shahid Beheshti Hospital, Kashan University of Medical Sciences

Abstract

The aim of this study was to investigate effects of aerobic exercise on plasma pentraxin-3 and C-reactive protein in diabetic and non-diabetic coronary artery disease (CAD) patients after revascularization interventions.59 male with CAD participate in our study and dedicated in intervention group (IG, n=29, weight: 76.58±11.25 Kg, age: 58.65±6.75 years, Diabetic/nondiabetic:14.15) and control group (CG, n= 30, weight: 76.13±14.79 Kg, age: 58.33±7.21, Diabetic/nondiabetic:15.15). Patients in IG performed 8 weeks aerobic exercise at 70 % of maximum heart rate, 3-4 times a week each session 60 min supervised by medical staff, CG has no physical activity program. Blood was drawn before and after 8 weeks to measure plasma levels of pentraxin 3(PTX3) and C-reactive protein (CRP). The analysis of variance (ANOVA) was used to compare pre-tests, post-tests were analyzed by using analysis of covariance (ANCOVA) with control of pre-tests value in P0.05). Aerobic exercise training can decrease plasma levels of PTX3 and CRP in CAD patients, aerobic exercise was more beneficial in non-diabetic than diabetic CAD patients.

Keywords

Main Subjects

References
  1. Rathmann W, Giani G. Global prevalence of diabetes: Estimates for the year 2000 and projections for 2030. Diabetes care. 2004;27(10):2568-9.
  2. Nishitani M, Shimada K, Masaki M, Sunayama S, Kume A, Fukao K, et al. Effect of cardiac rehabilitation on muscle mass, muscle strength, and exercise tolerance in diabetic patients after coronary artery bypass grafting. J. Cardiol.. 2013;61(3):216-21.
  3. Bari Investigators. The final 10-year follow-up results from the BARI randomized trial. J. Am. Coll. Cardiol. 2007;49(15):1600-6.
  4. Chatterjee S, Khunti K, Davies MJ. Type 2 diabetes. The Lancet. 2017 Jun 3;389(10085):2239-51.
  5. Teixeira de Lemos E, Oliveira J, Páscoa Pinheiro J, Reis F. Regular physical exercise as a strategy to improve antioxidant and anti-inflammatory status: Benefits in type 2 diabetes mellitus. Oxid. Med. Cell. Longevity. 2012; Aug 13.
  6. Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. Jama. 2001;286(3):327-34.
  7. Yang HS, Woo JE, Lee SJ, Park SH, Woo JM. Elevated plasma pentraxin 3 levels are associated with development and progression of diabetic retinopathy in Korean patients with type 2 diabetes mellitus elevated PTX3 in diabetic retinopathy. Invest. Ophthalmol. Visual Sci. 2014;55(9):5989-97.
  8. Shiraki A, Kotooka N, Komoda H, Hirase T, Oyama JI, Node K. Pentraxin-3 regulates the inflammatory activity of macrophages. Biochem. Biophys. Rep. 2016;5:290-5.
  9. Norata GD, Garlanda C, Catapano AL. The long pentraxin PTX3: A modulator of the immunoinflammatory response in atherosclerosis and cardiovascular diseases. Trends Cardiovasc. Med. 2010;20(2):35-40.
  10. Basati F, Sadeghi M, Golabchi A, Yazdekhasti S. Effects of a cardiac rehabilitation program on sys-tolic function and left ventricular mass in patients after myocardial infarction after revascularization. J. Res. Med. Sci. 2012;17: 28-32.
  11. Golabchi A, Basati F, Kargarfard M, Sadeghi M. Can cardiac rehabilitation programs improve functional capacity and left ventricular diastolic function in patients with mechanical reperfusion after ST elevation myocardial infarction? A double-blind clinical trial. ARYA Atheroscler.. 2012;8(3):125.
  12. Schramm TK, Gislason GH, Køber L, Rasmussen S, Rasmussen JN, Abildstrøm SZ, et al. Diabetes patients requiring glucose-lowering therapy and nondiabetics with a prior myocardial infarction carry the same cardiovascular risk. Circulation. 2008;117(15):1945-54.
  13. Emerging Risk Factors Collaboration. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. The Lancet. 2010 Jul 2;375(9733):2215-22.
  14. Armstrong MJ, Sigal RJ, Arena R, Hauer TL, Austford LD, Aggarwal S, et al. Cardiac rehabilitation completion is associated with reduced mortality in patients with diabetes and coronary artery disease. Diabetologia. 2015;58(4):691-8.
  15. Banzer JA, Maguire TE, Kennedy CM, O'Malley CJ, Balady GJ. Results of cardiac rehabilitation in patients with diabetes mellitus. Am. J. Cardiol. 2004;93(1):81-4.
  16. Karjalainen JJ, Kiviniemi AM, Hautala AJ, Piira OP, Lepojärvi ES, Perkiömäki JS, et al. Effects of physical activity and exercise training on cardiovascular risk in coronary artery disease patients with and without type 2 diabetes. Diabetes care. 2015: dc142216. 17. Ryan AS, Ge S, Blumenthal JB, Serra MC, Prior SJ, Goldberg AP. Aerobic exercise and weight loss reduce vascular markers of inflammation and improve insulin sensitivity in obese women. J. Am. Geriatr. Soc. 2014;62(4):607-14.
  17. Balducci S, Zanuso S, Nicolucci A, Fernando F, Cavallo S, Cardelli P, et al. Anti-inflammatory effect of exercise training in subjects with type 2 diabetes and the metabolic syndrome is dependent on exercise modalities and independent of weight loss. Nutr., Metab. Cardiovasc. Dis. 2010;20(8):608-17.
  18. Brozic AP, Marzolini S, Goodman JM. Effects of an adapted cardiac rehabilitation programme on arterial stiffness in patients with type 2 diabetes without cardiac disease diagnosis. Diabetes Vasc. Dis. Res. 2017;14(2):104-12
  19. Noonan V, Dean E. Submaximal exercise testing: clinical application and interpretation. Phys. Ther. 2000;80(8):782-807.
  20. Forhan M, Zagorski BM, Marzonlini S, Oh P, Alter DA. Predicting exercise adherence for patients with obesity and diabetes referred to a cardiac rehabilitation and secondary prevention program. Can. J. Diabetes. 2013;37(3):189-94.
  21. Fukuda T, Kurano M, Iida H, Takano H, Tanaka T, Yamamoto Y, et al. Cardiac rehabilitation decreases plasma pentraxin 3 in patients with cardiovascular diseases. Eur. J. Prev. Cardiol. 2012;19(6):1393-400.
  22. Haybar H, Payami B, Khaheshi I, Ghotbi Y, Latifi SM, Assareh A. Interesting correlation between the circulating pentraxin 3 and cardiac rehabilitation program outcomes in coronary artery bypass grafting patients. Cardiol Res. 2016;7(2):59-65.
  23. Ferratini M, Ripamonti V, Masson S, Grati P, Racca V, Cuccovillo I, et al. Pentraxin-3 predicts functional recovery and 1-year major adverse cardiovascular events after rehabilitation of cardiac surgery patients. J Cardiopulm. Rehabil. Prev. 2012;32(1),17-24.
  24. Madsen SM, Thorup AC, Bjerre M, Jeppesen PB. Does 8 weeks of strenuous bicycle exercise improve diabetes-related inflammatory cytokines and free fatty acids in type 2 diabetes patients and individuals at high-risk of metabolic syndrome? Arch. Physiol. Biochem. 2015;121(4):129-38.
  25. Zempo-Miyaki A, Fujie S, Sato K, Hasegawa N, Sanada K, Maeda S, et al. Elevated pentraxin 3 level at the early stage of exercise training is associated with reduction of arterial stiffness in middle-aged and older adults. J. Hum. Hypertens. 2015;30(9):521-6.
  26. Miyaki A, Maeda S, Choi Y, Akazawa N, Tanabe Y, Ajisaka R. Habitual aerobic exercise increases plasma pentraxin 3 levels in middle-aged and elderly women. Appl. Physiol., Nutr., Metab. 2012;37(5):907-11.
  27. Hayashino Y, Jackson JL, Hirata T, Fukumori N, Nakamura F, Fukuhara S, et al. Effects of exercise on C-reactive protein, inflammatory cytokine and adipokine in patients with type 2 diabetes: a meta-analysis of randomized controlled trials. Metabolism. 2014;63(3):431-40.
  28. Kadoglou NP, Perrea D, Iliadis F, Angelopoulou N, Liapis C, Alevizos M. Exercise reduces resistin and inflammatory cytokines in patients with type 2 diabetes. Diabetes care. 2007;30(3):719-21.
  29. Kadoglou NP, Iliadis F, Liapis CD, Perrea D, Angelopoulou N, Alevizos M. Beneficial effects of combined treatment with rosiglitazone and exercise on cardiovascular risk factors in patients with type 2 diabetes. Diabetes Care. 2007;30(9):2242-4.
  30. Oberbach A, Tönjes A, Klöting N, Fasshauer M, Kratzsch J, Busse MW, et al. Effect of a 4-week physical training program on plasma concentrations of inflammatory markers in patients with abnormal glucose tolerance. Eur. J. Endocrinol. 2006;154(4):577-85.
  31. Swardfager W, Herrmann N, Cornish S, Mazereeuw G, Marzolini S, et al. Exercise intervention and inflammatory markers in coronary artery disease: a meta-analysis. Am. Heart J. 2012;163(4):666-76.
  32. Wang TD, Chen WJ, Cheng WC, Lin JW, Chen MF, Lee YT. Relation of improvement in endothelium-dependent flow-mediated vasodilation after rosiglitazone to changes in asymmetric dimethylarginine, endothelin-1, and C-reactive protein in nondiabetic patients with the metabolic syndrome. Am. J. Cardiol. 2006;98(8):1057-62.
  33. Ryan AS, Ge S, Blumenthal JB, Serra MC, Prior SJ, Goldberg AP. Aerobic exercise and weight loss reduce vascular markers of inflammation and improve insulin sensitivity in obese women. J. Am. Geriatr. Soc. 2014;62(4):607-14.
  34. Khoo J, Dhamodaran S, Chen DD, Yap SY, Chen RY, Tian RH. Exercise-induced weight loss is more effective than dieting for improving adipokine profile, insulin resistance, and inflammation in obese men. Int. J. Sport Nutr. Exercise Metab. 2015;25(6):566-75.
  35. Pedersen LR, Olsen RH, Anholm C, Walzem RL, Fenger M, Eugen-Olsen J, Haugaard SB, Prescott E. Weight loss is superior to exercise in improving the atherogenic lipid profile in a sedentary, overweight population with stable coronary artery disease: A randomized trial. Atherosclerosis. 2016;246:221-8.
  36. Miller EG, Sethi P, Nowson CA, Dunstan DW, Daly RM. Effects of progressive resistance training and weight loss versus weight loss alone on inflammatory and endothelial biomarkers in older adults with type 2 diabetes. Eur. J. Appl. Physiol. 2017;117(8):1669-78.
  37. Nicklas BJ, Ambrosius W, Messier SP, Miller GD, Penninx BW, Loeser RF, et al. Diet-induced weight loss, exercise, and chronic inflammation in older, obese adults: A randomized controlled clinical trial. Am. J. Clin. Nutr. 2004;79(4):544-51.
Sport Physiology
Volume 10, Issue 38
Summer 2018
August 2018
Pages 163-180
Files
History
  • Receive Date: 20 May 2017
  • Revise Date: 30 December 2017
  • Accept Date: 10 January 2018
Share
How to cite
Statistics